Who are Pyrojas's investors?

Pyrojas's investors include Ulu Ventures.

Pyrojas

1 known investors

Pyrojas develops whole-cell cancer vaccines engineered from patients' own tumors to activate T cell responses against multiple antigens. The company focuses on precision immunotherapy for cancer treatment.

AI & Machine Learning Biotech Medical Devices

Founders & leadership

Board

James AllisonNobel Laureate

Investors · 1

Ulu VenturesPalo Alto · $2M

Competitors · 1

by search overlap

Umoja Biopharma, Inc.4 shared keywordsUmoja Biopharma develops in vivo CAR T cell cancer therapies using its VivoVec platform, which generates chimeric antigen receptor T cells directly inside a patient's body rather than through the traditional ex vivo process. The company operates its own in-house manufacturing to supply its therapeutics.

Companies competing with Pyrojas for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Pyrojas do?: Pyrojas develops whole-cell cancer vaccines engineered from patients' own tumors to activate T cell responses against multiple antigens. The company focuses on precision immunotherapy for cancer treatment.
Who are Pyrojas's investors?: Pyrojas's investors include Ulu Ventures.